Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation

Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation

Paris, December 19, 2025. Sanofi today announced an agreement with President Donald J. Trump's Administration to help ensure American patients have access to more affordable medicines while also supporting the role of the US in biopharmaceutical manufacturing and innovation. With this agreement, Sanofi confirms its growth strategy to take the lead through breakthrough science and by striving to be a driver of progress and positive impact for the people and communities it serves.